EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieValidierungsstudieOpen Access · CC BY-NC-ND 4.0

Development and validation of a novel prognostic score to improve prognostic prediction in patients with type B aortic dissection

Xingfeng Chen, Linfeng Xie, Qingsong Wu, Siying Luo, Zhisheng Wang, Yikun Jiang, Xinfan Lin, Xu Han, Zhihuang Qiu, Liangwan Chen

Journal of Vascular Surgery · 2025

DOI: 10.1016/j.jvs.2025.06.018 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Xingfeng Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, P.R. China; Key Laboratory of Cardio-Thoracic Surgery…. Hauptthemen laut MEDLINE: Aortic Aneurysm, Thoracic, Aortic Dissection, Blood Vessel Prosthesis Implantation, Decision Support Techniques. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Fujian Provincial Special Reserve Talents Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Type B aortic dissection (TBAD) is a life-threatening aortic disease with an increasing incidence, which requires accurate risk stratification tools for thoracic endovascular aortic repair (TEVAR). This multicenter retrospective study aimed to enhance the risk prediction of severe adverse events post TEVAR in patients with TBAD by improving the Age, Creatinine, and Ejection Fraction (ACEF) score. METHODS: This multicenter retrospective study enrolled 547 patients with TBAD who underwent TEVAR between 2015 and 2020. The training cohort (n = 382) from Fujian Medical University Union Hospital was used for model development, whereas the validation cohort (n = 165) from two external centers evaluated performance. Independent risk factors were identified using multivariate logistic regression. The novel composite risk score (ACEF-TBAD) combined age, creatinine, and ejection fraction with hypertension, D-dimer/fibrinogen ratio (DFR), and interleukin-6 (IL-6). Model performance was assessed using receiver operating characteristic curve, calibration curves, decision curve analysis, and reclassification indices. RESULTS: The ACEF-TBAD score demonstrated superior predictive accuracy compared with the original ACEF, modified ACEF, and EuroSCORE II models, with area under the curve values of 0.922 in the training dataset and 0.829 in the validation dataset. Key determinants included hypertension (odds ratio [OR], 4.84; 95% confidence interval [CI], 2.03-11.58; P .05) and net clinical benefit (decision curve analysis curve). Reclassification analysis revealed significant improvements in risk stratification (net reclassification index, 0.366 in training; 0.206 in validation). The survival curves clearly demonstrated that the ACEF-TBAD score effectively stratified patients into distinct risk categories, which underscores the clinical utility of the ACEF-TBAD score in predicting severe adverse events and supports its use in risk assessment for patients with TBAD. CONCLUSIONS: The ACEF-TBAD score is a novel and simple risk-stratification tool. This enables early identification of high-risk patients, facilitating personalized treatment and improving patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, ThoracicAortic DissectionBlood Vessel Prosthesis ImplantationDecision Support TechniquesEndovascular ProceduresAgedFemaleHumansMaleMiddle AgedBiomarkersCreatininePredictive Value of TestsPrognosisReproducibility of ResultsRetrospective StudiesRisk AssessmentRisk FactorsStroke VolumeTreatment Outcome

Stichwörter der Autor:innen

Multicenter retrospective studyRisk predictionSevere adverse eventsThoracic endovascular aortic repairType B aortic dissection

Substanzen

BiomarkersCreatinine

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, P.R. China; Key Laboratory of Cardio-Thoracic Surgery, Fujian Province University, Fuzhou, Fujian, P.R. China; Department o…
  • Department of Cardiovascular Surgery, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, P.R. China.
  • Department of Cardiovascular Surgery, Nanping First Affiliated Hospital of Fujian Medical University, Nanping, Fujian, P.R. China.

Förderung

  • the Fujian Provincial Special Reserve Talents Laboratory

Zitieren

APA

Chen, X., Xie, L., Wu, Q., Luo, S., Wang, Z., Jiang, Y., Lin, X., Han, X., Qiu, Z., & Chen, L. (2025). Development and validation of a novel prognostic score to improve prognostic prediction in patients with type B aortic dissection. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.06.018

Vancouver

Chen X, Xie L, Wu Q, Luo S, Wang Z, Jiang Y, et al. Development and validation of a novel prognostic score to improve prognostic prediction in patients with type B aortic dissection. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2025.06.018

BibTeX
@article{Chen2025,
  author = {Chen, Xingfeng and Xie, Linfeng and Wu, Qingsong and Luo, Siying and Wang, Zhisheng and Jiang, Yikun and Lin, Xinfan and Han, Xu and Qiu, Zhihuang and Chen, Liangwan},
  title = {Development and validation of a novel prognostic score to improve prognostic prediction in patients with type B aortic dissection},
  journal = {Journal of Vascular Surgery},
  year = {2025},
  doi = {10.1016/j.jvs.2025.06.018}
}
Kostenlos starten →